Top entities: Teladoc Health, Pomerantz LLP, BetterHelp.

What category does this event fall under?

Regulatory — classified as securities investigation.

What is the sentiment of coverage?

Aggregate sentiment score: -60 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

What were the key actions taken?

Teladoc Health cut revenue guidance · Pomerantz LLP launched investigation Teladoc Health

Is this event still developing?

This is an active story, last updated Aug 20, 2026. Coverage continues to evolve.

Regulatory securities investigation

Teladoc guidance cut triggers investigation

Q: When did this event occur?

First reported Aug 07, 2026; last updated Aug 20, 2026.

Q: What is the market impact?

General. Teladoc's stock plunged 38% after the guidance cut, reflecting investor concerns about the company's growth prospects and business model transition.

Analysis based on 6 articles · First reported Aug 07, 2026 · Last updated Aug 20, 2026

Sentiment

-60

Attention

Articles

Market Impact

General

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

Teladoc's stock plunged 38% after the guidance cut, reflecting investor concerns about the company's growth prospects and business model transition. The investigation by Pomerantz LLP adds legal and reputational risk, potentially further pressuring the stock and increasing volatility.

Telehealth Healthcare

Event Summary

Teladoc Health reported Q2 2026 results on July 29, 2026, and cut its full-year 2026 revenue guidance to $2.36-$2.45 billion from $2.48-$2.58 billion, citing uncertainties in cash pay and business model transition, as well as pressures on its BetterHelp platform including faster insurance preference, accelerated cash pay decline, and network capacity lagging demand. The stock fell 38.32% to $6.58 per share on July 30. Pomerantz LLP launched an investigation into whether Teladoc and certain officers/directors engaged in securities fraud or unlawful business practices, and is seeking investors to join a potential class action.

Key Actions

90 Teladoc Health cut revenue guidance

70 Pomerantz LLP launched investigation Teladoc Health

Entities Involved

stock

Teladoc Health

Teladoc is the subject of the investigation and the company that cut its revenue guidance, causing a 38% stock drop. The investigation and guidance cut negatively impact its financial outlook and investor confidence.

Importance 100.0 Sentiment -80.0

priv

Pomerantz LLP

Pomerantz LLP is the law firm investigating Teladoc for potential securities fraud. The investigation could lead to a class action lawsuit, potentially benefiting the firm and its clients.

Importance 70.0 Sentiment 20.0

priv

BetterHelp

BetterHelp is Teladoc's platform facing pressures such as faster insurance preference, accelerated cash pay decline, and network capacity lagging demand, contributing to the guidance cut and negative sentiment.

Importance 50.0 Sentiment -50.0

ERGEN INTELLIGENCE

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard